相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immunogenicity of biologic agents in rheumatology
Vibeke Strand et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics
Yu Chen et al.
ACTA BIOMATERIALIA (2021)
The gut-joint axis in rheumatoid arthritis
Mario M. Zaiss et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study
Marja K. Puurunen et al.
NATURE METABOLISM (2021)
Immunogenicity of TNF-Inhibitors
Sadaf Atiqi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Challenges and Pitfalls in the Engineering of Human Interleukin 22 (hIL-22) SecretingLactobacillus reuteri
Laura Ortiz-Velez et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Modulation of Lymphocyte Potassium Channel KV1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin
Seow Theng Ong et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Non-invasive delivery strategies for biologics
Aaron C. Anselmo et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
Pichet Praveschotinunt et al.
NATURE COMMUNICATIONS (2019)
KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis
Mark R. Tanner et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors A Systematic Review and Meta-analysis
Jawad Bilal et al.
JAMA NETWORK OPEN (2019)
Characterizing how probiotic Lactobacillus reuteri 6475 and lactobacillic acid mediate suppression of osteoclast differentiation
Darin Quach et al.
BONE REPORTS (2019)
Targeting KCa1.1 Channels with a Scorpion Venom Peptide for the Therapy of Rat Models of Rheumatoid Arthritis
Mark R. Tanner et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Role of Lactobacillus reuteri in Human Health and Diseases
Qinghui Mu et al.
FRONTIERS IN MICROBIOLOGY (2018)
Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications
Jae-hyuck Shim et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
KCa1.1 channels as therapeutic targets for rheumatoid arthritis
Christine Beeton
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
The Therapeutic Benefit of Bacterial Membrane Vesicles
Natalie J. Bitto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth
Lian He et al.
ONCOTARGET (2017)
Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial
Eric J. Tarcha et al.
PLOS ONE (2017)
B-cell phenotype and IgD-CD27-memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis
Rita A. Moura et al.
PLOS ONE (2017)
Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats
Ralf Bergmann et al.
SCIENTIFIC REPORTS (2017)
The Potential of Probiotics as a Therapy for Osteoporosis
Fraser L. Collins et al.
MICROBIOLOGY SPECTRUM (2017)
Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease
K. George Chandy et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2017)
Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog
Mark R. Tanner et al.
CLINICAL IMMUNOLOGY (2017)
Enabling Noninvasive Systemic Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] via the Buccal Mucosa
Liang Jin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] for the Treatment of Autoimmune Diseases
Liang Jin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Lactobacillus reuteri 6475 Increases Bone Density in Intact Females Only under an Inflammatory Setting
Fraser L. Collins et al.
PLOS ONE (2016)
Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK
Michael W. Pennington et al.
MARINE DRUGS (2015)
Enhancing the Buccal Mucosal Delivery of Peptide and Protein Therapeutics
Thiago Caon et al.
PHARMACEUTICAL RESEARCH (2015)
KCa1.1 Inhibition Attenuates Fibroblast-like Synoviocyte Invasiveness and Ameliorates Disease in Rat Models of Rheumatoid Arthritis
Mark R. Tanner et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking
Charles A. Galea et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Probiotic L. reuteri Treatment Prevents Bone Loss in a Menopausal Ovariectomized Mouse Model
Robert A. Britton et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases
M. Harunur Rashid et al.
SCIENTIFIC REPORTS (2014)
Engineering Signal Peptides for Enhanced Protein Secretion from Lactococcus lactis
Daphne T. W. Ng et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2013)
Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice
Laura R. Mccabe et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes
Shyny Koshy et al.
PLOS ONE (2013)
Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn's disease and rheumatoid arthritis: Results of a systematic review
Herma H. Fidder et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Identification of Two New Arthritis Severity Loci That Regulate Levels of Autoantibodies, Interleukin-1β, and Joint Damage in Pristane- and Collagen-Induced Arthritis
Max Brenner et al.
ARTHRITIS AND RHEUMATISM (2012)
Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature
Bart J. F. van den Bemt et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2012)
KCa1.1 Potassium Channels Regulate Key Proinflammatory and Invasive Properties of Fibroblast-like Synoviocytes in Rheumatoid Arthritis
Xueyou Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria
Shih Chieh Chang et al.
TOXICON (2012)
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
Victor Chi et al.
TOXICON (2012)
Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease
Eric J. Tarcha et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Imaging of Effector Memory T Cells during a Delayed-Type Hypersensitivity Reaction and Suppression by Kv1.3 Channel Block
Melanie P. Matheu et al.
IMMUNITY (2008)
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Christine Beeton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The heart and cardiovascular manifestations in rheumatoid arthritis
A. E. Voskuyl
RHEUMATOLOGY (2006)
High-level, inducible gene expression in Lactobacillus sakei and Lactobacillus plantarum using versatile expression vectors
E Sorvig et al.
MICROBIOLOGY-SGM (2005)
Phenotypic and functional characterisation of CCR7(+) and CCR7(-) CD4(+) memory T cells homing to the joints in juvenile idiopathic arthritis
M Gattorno et al.
ARTHRITIS RESEARCH & THERAPY (2005)
K+ channel expression during B cell differentiation:: Implications for immunomodulation and autoimmunity
H Wulff et al.
JOURNAL OF IMMUNOLOGY (2004)
The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
H Wulff et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes
C Beeton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis
C Beeton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)